BACKGROUND:Heart failure (HF) disease management can improve health outcomes for older community dwelling patients with heart failure. HF disease management has not been studied in skilled nursing facilities, a major site of transitional care for older adults. METHODS AND ANTICIPATED RESULTS: The objective of this trial is to investigate if a HF- disease management program (HF-DMP) in skilled nursing facilities (SNF)s will decrease all-cause rehospitalizations for the first 60 days post-SNF admission. The trial is a randomized cluster trial to be conducted in 12 for-profit SNF in the greater Cleveland area. The study population is inclusive of patients with HF regardless of ejection fraction but excludes those patients on dialysis and with a life expectancy of 6 months or less. The HF-DMP includes 7 elements considered standard of care for patients with HF documentation of left ventricular function, tracking of weight and symptoms, medication titration, discharge instructions, 7-day follow-up appointment post-SNF discharge, and patient education. The HF-DMP is conducted by a research nurse tasked with adhering to each element of the program and regularly audited to maintain fidelity of the program. Additional outcomes include health status, self-care management, and discharge destination. CONCLUSIONS: The SNF-Connect Trial is the first trial of its kind to assess if a HF-DMP will improve outcomes for patients in SNFs. This trial will provide evidence on the effectiveness of HF-DMP to improve outcomes for older frail HF patients undergoing postacute rehabilitation.
RCT Entities:
BACKGROUND:Heart failure (HF) disease management can improve health outcomes for older community dwelling patients with heart failure. HF disease management has not been studied in skilled nursing facilities, a major site of transitional care for older adults. METHODS AND ANTICIPATED RESULTS: The objective of this trial is to investigate if a HF- disease management program (HF-DMP) in skilled nursing facilities (SNF)s will decrease all-cause rehospitalizations for the first 60 days post-SNF admission. The trial is a randomized cluster trial to be conducted in 12 for-profit SNF in the greater Cleveland area. The study population is inclusive of patients with HF regardless of ejection fraction but excludes those patients on dialysis and with a life expectancy of 6 months or less. The HF-DMP includes 7 elements considered standard of care for patients with HF documentation of left ventricular function, tracking of weight and symptoms, medication titration, discharge instructions, 7-day follow-up appointment post-SNF discharge, and patient education. The HF-DMP is conducted by a research nurse tasked with adhering to each element of the program and regularly audited to maintain fidelity of the program. Additional outcomes include health status, self-care management, and discharge destination. CONCLUSIONS: The SNF-Connect Trial is the first trial of its kind to assess if a HF-DMP will improve outcomes for patients in SNFs. This trial will provide evidence on the effectiveness of HF-DMP to improve outcomes for older frail HF patients undergoing postacute rehabilitation.
Authors: Michael Pignone; Darren A DeWalt; Stacey Sheridan; Nancy Berkman; Kathleen N Lohr Journal: J Gen Intern Med Date: 2005-02 Impact factor: 5.128
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Rebecca S Boxer; Mary A Dolansky; Megan A Frantz; Regina Prosser; Jeanne A Hitch; Ileana L Piña Journal: J Am Med Dir Assoc Date: 2011-03-11 Impact factor: 4.669
Authors: Dan K Kiely; Edward R Marcantonio; Sharon K Inouye; Michele L Shaffer; Margaret A Bergmann; Frances M Yang; Michael A Fearing; Richard N Jones Journal: J Am Geriatr Soc Date: 2009-01 Impact factor: 5.562
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Andrea E Daddato; Blythe Dollar; Hillary D Lum; Robert E Burke; Rebecca S Boxer Journal: J Am Med Dir Assoc Date: 2019-06-18 Impact factor: 4.669
Authors: Lee A Lindquist; Rachel K Miller; Wayne S Saltsman; Jennifer Carnahan; Theresa A Rowe; Alicia I Arbaje; Nicole Werner; Kenneth Boockvar; Karl Steinberg; Shahla Baharlou Journal: J Gen Intern Med Date: 2016-10-04 Impact factor: 5.128
Authors: Andrea Daddato; Heidi L Wald; Carolyn Horney; Diane L Fairclough; Erin C Leister; Marilyn Coors; Warren H Capell; Rebecca S Boxer Journal: Clin Trials Date: 2017-01-31 Impact factor: 2.486
Authors: Allison M Gustavson; Rebecca S Boxer; Amy Nordon-Craft; Robin L Marcus; Andrea Daddato; Jennifer E Stevens-Lapsley Journal: Phys Ther J Policy Adm Leadersh Date: 2018-08
Authors: Himali Weerahandi; Erin L Chaussee; John A Dodson; Mary Dolansky; Rebecca S Boxer Journal: J Am Med Dir Assoc Date: 2021-09-01 Impact factor: 4.669
Authors: George A Heckman; Veronique M Boscart; Kelsey Huson; Andrew Costa; Karen Harkness; John P Hirdes; Paul Stolee; Robert S McKelvie Journal: Pilot Feasibility Stud Date: 2017-07-06